Cargando…

A case of neonatal-onset autoinflammatory syndrome with a de novo PSMB9 mutation resembling Nakajo-Nishimura syndrome

Detalles Bibliográficos
Autores principales:	Kinjo, N, Kanazawa, N, Mishima, H, Kinoshita, A, Yoshiura, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599820/ http://dx.doi.org/10.1186/1546-0096-13-S1-P183

Ejemplares similares

Nakajo–Nishimura syndrome and related proteasome-associated autoinflammatory syndromes
por: Ohmura, Koichiro
Publicado: (2019)

Beneficial effect of methotrexate on a case of Nakajo-Nishimura syndrome
por: Kunimoto, K, et al.
Publicado: (2015)

A Chinese case of Nakajo–Nishimura syndrome with novel compound heterozygous mutations of the PSMB8 gene
por: Jia, Tao, et al.
Publicado: (2020)

Induced pluripotent stem cells representing Nakajo-Nishimura syndrome
por: Kanazawa, Nobuo, et al.
Publicado: (2019)

Nakajo-Nishimura Syndrome: The First African Case
por: Ghodbane, Nacif Eddine, et al.
Publicado: (2023)

90 Nakajo-Nishimura syndrome: a case report
por: Halima, Zerguine, et al.
Publicado: (2022)

53 Nakajo-Nishimura syndrome: the first African case
por: Ghodbane, Nacif Eddine, et al.
Publicado: (2022)

Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress
por: Honda-Ozaki, Fumiko, et al.
Publicado: (2018)

Pluripotent stem cell‐based screening identifies CUDC‐907 as an effective compound for restoring the in vitro phenotype of Nakajo‐Nishimura syndrome
por: Kase, Naoya, et al.
Publicado: (2020)

Correction to: Pluripotent Stem Cell-Based Screening Identifies CUDC-907 as an Effective Compound for Restoring the In Vitro Phenotype of Nakajo-Nishimura Syndrome
Publicado: (2022)

Temporal changes of serum cytokine/chemokine levels in patients of Nakajo-Nishimra syndrome treated with tocilizumab
por: Kanazawa, N, et al.
Publicado: (2015)

8. An autoinflammatory syndrome resembling Castleman’s disease with excellent response to IL-6 blockade
por: Chakravorty, Mithun, et al.
Publicado: (2019)

Sequence Variants in PSMB8/PSMB9 Immunoproteasome Genes and Risk of Urothelial Bladder Carcinoma
por: Elhawary, Nasser A, et al.
Publicado: (2023)

Case report: De novo SAMD9L truncation causes neonatal-onset autoinflammatory syndrome which was successfully treated with hematopoietic stem cell transplantation
por: Caldirola, María Soledad, et al.
Publicado: (2023)

A Case of Familial Cold Autoinflammatory Syndrome with De Novo NLRP3 Mutation
por: Zhang, Wenqing, et al.
Publicado: (2021)

Restoring one way traffic across the Roux loop: The Nakajo value
por: Rammohan, Ashwin, et al.
Publicado: (2018)

Is Still's Disease an Autoinflammatory Syndrome?
por: Rossi-Semerano, Linda, et al.
Publicado: (2012)

Autoinflammatory syndromes: diagnosis and management
por: De Sanctis, Sara, et al.
Publicado: (2010)

Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers
por: Geoffroy, Karen, et al.
Publicado: (2023)

VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
por: Vitale, Antonio, et al.
Publicado: (2023)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

P02-016 - A novel PSMB8 mutation causing candle syndrome
por: Messia, V, et al.
Publicado: (2013)

PReS-FINAL-2202: A novel PSMB8 mutation associated with CANDLE syndrome
por: Insalaco, A, et al.
Publicado: (2013)

Autoinflammatory disease: clinical perspectives and therapeutic strategies
por: Kawakami, Atsushi, et al.
Publicado: (2022)

Heterozygous missense variant of the proteasome subunit β-type 9 causes neonatal-onset autoinflammation and immunodeficiency
por: Kanazawa, Nobuo, et al.
Publicado: (2021)

Identification of PSMB5 as a genetic modifier of fragile X–associated tremor/ataxia syndrome
por: Kong, Ha Eun, et al.
Publicado: (2022)

Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
por: Urien, Saik, et al.
Publicado: (2013)

Diversity in clinical manifestations of autoinflammatory syndromes
por: Boiu, S, et al.
Publicado: (2011)

Periodic fever syndrome and autoinflammatory diseases
por: Dickie, Laura J, et al.
Publicado: (2010)

OR6-002 – Thromboembolism in autoinflammatory syndromes
por: Vaitla, PM, et al.
Publicado: (2013)

Correction: Autoinflammatory disease: clinical perspectives and therapeutic strategies
por: Kawakami, Atsushi, et al.
Publicado: (2022)

IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome
por: Baggio, Chiara, et al.
Publicado: (2023)

A de novo nonsense mutation in the tyrosine kinase lyn in a patient with an early onset autoinflammatory phenotype
por: De Jesus, Adriana Almeida, et al.
Publicado: (2014)

The Relationship between NALP3 and Autoinflammatory Syndromes
por: Campbell, Lorna, et al.
Publicado: (2016)

Periodic fever syndromes and the autoinflammatory diseases (AIDs)
por: Marino, Achille, et al.
Publicado: (2019)

Hereditary systemic autoinflammatory diseases and Schnitzler’s syndrome
por: Kacar, Mark, et al.
Publicado: (2019)

Pathological and immunological features of autoinflammatory syndrome associated with lymphedema (AISLE)
por: Gul, A, et al.
Publicado: (2015)

Designation of Autoinflammatory Skin Manifestations With Specific Genetic Backgrounds
por: Kanazawa, Nobuo
Publicado: (2020)

Differentiation of preadipocytes and mature adipocytes requires PSMB8
por: Arimochi, Hideki, et al.
Publicado: (2016)

Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML
por: Zhang, Yongping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2gq8u1psp4756itciq6t1tr502